Compare CTRA & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CTRA | HOLX |
|---|---|---|
| Founded | 1989 | 1985 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical Electronics |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.6B | 16.6B |
| IPO Year | N/A | N/A |
| Metric | CTRA | HOLX |
|---|---|---|
| Price | $31.51 | $75.22 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 15 | 13 |
| Target Price | $33.00 | ★ $77.89 |
| AVG Volume (30 Days) | ★ 11.7M | 2.6M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 2.79% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $46.24 | $6.01 |
| Revenue Next Year | $2.69 | $5.29 |
| P/E Ratio | ★ $14.55 | $31.27 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.33 | $51.90 |
| 52 Week High | $31.81 | $75.36 |
| Indicator | CTRA | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 68.86 | 59.91 |
| Support Level | $30.60 | $74.89 |
| Resistance Level | $31.66 | $75.29 |
| Average True Range (ATR) | 0.96 | 0.24 |
| MACD | 0.15 | 0.02 |
| Stochastic Oscillator | 91.89 | 91.14 |
Coterra Energy Inc is an independent oil and gas company engaged in the development, exploration, and production of oil, natural gas, and natural gas liquids (NGLs). Its operations are mainly concentrated in areas with hydrocarbon resources, which are conducive to multi-well, repeatable development programs, and include the Permian Basin located in Texas and New Mexico, the Marcellus Shale in northeast Pennsylvania, and the Anadarko Basin located in the mid-continent region in Oklahoma. The company operates in one segment, oil and natural gas development, exploration, and production, in the continental U.S.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.